期刊文献+

血液灌流联合血液透析治疗尿毒症难治性高血压的临床研究 被引量:29

下载PDF
导出
摘要 慢性肾衰竭患者中80%-90%伴有高血压,部分患者经常规血液透析(HD),充分透析和超滤脱水后,达到干体重,血压仍未能恢复正常,部分甚至更高,经联合应用足量的降压药物三联以上,仍出现持续性高血压,为尿毒症难治性高血压(RH)。广东省佛山市顺德区容奇医院自2001年9月-2008年3月,共收治慢性肾衰竭(尿毒症期)患者195例,其中达到上述难治性高血压标准者42例,发生率为21.5%。为探讨有效的治疗方法,我们将42例患者随机分为联合血液灌流(HP)组和单纯血液透析(HD)组.对比了联合血液灌流和单纯血液透析在治疗尿毒症RH的疗效。报道如下:
作者 赵冰峰
出处 《中国血液净化》 2008年第9期516-517,共2页 Chinese Journal of Blood Purification
  • 相关文献

参考文献6

二级参考文献26

  • 1[1]Mikhalovsky SV. emerging technologies in extracorporeal treatment:focus on adsorption. Perfusion, 2003,18(7) :47 - 54
  • 2[2]Vanholder R. Review on uremic toxins: Classification, concentration,and interindividual variability. Kidney International,2003,63(5): 1934- 1943
  • 3[3]James F. Removal of Middle Molecules with Sorbents. Artif Cells Blood Substit Immobil Biotechnol, 2002,30(5- 6):547- 554
  • 4[4]Clark WR. Middle molecules and small- molecular- weight protiens in ESRD: Properties and strategies for their removal. Adv Ren Replace Ther,2003, 10(4) :270 - 278
  • 5[5]Morena MD. Effect of novel adsorbent on cytokine responsiveness to uremic plasma. Kidney Int,2003,63(3):1150-4
  • 6[6]Winchester JF. The next step from high - flux dialysis: application of sorbent technology. Blood Purif, 2002,20(1):81-6
  • 7[7]Vanholder R. Survival of hemodialysis patients uremic toxin removal.Artifi Organ,2003,27 (7) :218 - 23
  • 8[9]Schlaeper C. High clearance continuious renal replacement therapy with a modified dialysis machine. Kidney Int Suppl, 1999,72(56): S20 - 3
  • 9[10]Lesaffer G. Comparative kinetics of the uremic toxin p - cresol versus creatinine in rats with and without renal failure. Kidney Int, 2003, 64(4): 1365 - 73
  • 10[11]Fagugli RM. Behavior of non - protein- bound and protein- bound uremic solutes during daily hemodialysis. Am J Kidney Dis, 2002,40(2) :339 - 47

共引文献152

同被引文献166

引证文献29

二级引证文献287

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部